VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Shane Stokes
December 16, 2017
Michelton-Scott team names Adam Yates as leader for 2018 Tour de France; Esteban Chaves and Simon Yates to take on Giro d’Italia/Vuelta a Espana campaign; Ruffoni handed a four year ban over GHRP doping positive; Anti-doping chief aghast at Flanders invitation to Armstrong; Lobato was hospitalised over sleep medication, LottoNL-Jumbo riders face possible sacking; Silca calls for stop-use on SuperPista floor pumps; Video: Road rage Italian (cycling) style; Video: Phils Gaimon’s Worst Retirement Ever, Episode 10 – Mt. Washington Hillclimb; Video: Eurosport looks back at Milan-San Remo
A little over seven months after it emerged that Nicola Ruffoni and his Bardiani-CSF teammate Stefano Pirazzi had tested positive for GH-Releasing Peptides (GHRPs) in out of competition tests prior to the Giro d’Italia, Ruffoni’s sanction has been confirmed.
“The Union Cycliste Internationale (UCI) announces that the UCI Anti-Doping Tribunal has rendered its decision in the case involving Nicola Ruffoni,” it said in a statement on Thursday. “The Anti-Doping Tribunal found the rider guilty of an anti-doping rule violation (presence of GH-Releasing Peptides /GHRPs)* and imposed 4-year period of ineligibility on the rider.”
It added that “in accordance with the Procedural Rules of the Anti-Doping Tribunal, the decision will shortly be published on the UCI website.”
Ruffoni was tested on April 25 while Pirazzi was subjected to an anti-doping control the following day. The latter was handed a four year ban in early October. That was listed as beginning on April 26 and running until May 3 2021.
The Bardiani CSF team stated on May 19 that their B samples had backed up the initial result and that both riders had been fired. It said then that it “reserves the right to proceed with a legal action against Pirazzi and Ruffoni to protect the image of the team and its sponsor.”